NO910395L - Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater.Info
- Publication number
- NO910395L NO910395L NO91910395A NO910395A NO910395L NO 910395 L NO910395 L NO 910395L NO 91910395 A NO91910395 A NO 91910395A NO 910395 A NO910395 A NO 910395A NO 910395 L NO910395 L NO 910395L
- Authority
- NO
- Norway
- Prior art keywords
- isoxazolcarboxamide
- derivatives
- preparation
- therapeutic effective
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/474,430 US5001124A (en) | 1990-02-02 | 1990-02-02 | 4-isoxazolecarboxamide derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO910395D0 NO910395D0 (no) | 1991-02-01 |
| NO910395L true NO910395L (no) | 1991-08-05 |
Family
ID=23883499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91910395A NO910395L (no) | 1990-02-02 | 1991-02-01 | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US5001124A (fi) |
| EP (1) | EP0440503A1 (fi) |
| JP (1) | JPH06340641A (fi) |
| KR (1) | KR910021388A (fi) |
| AU (1) | AU643494B2 (fi) |
| CA (1) | CA2035544A1 (fi) |
| FI (1) | FI910503A (fi) |
| HU (1) | HUT60479A (fi) |
| IE (1) | IE910348A1 (fi) |
| IL (1) | IL97050A0 (fi) |
| NO (1) | NO910395L (fi) |
| NZ (1) | NZ236985A (fi) |
| PH (1) | PH27573A (fi) |
| PT (1) | PT96633A (fi) |
| TW (1) | TW207534B (fi) |
| ZA (1) | ZA91782B (fi) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5258397A (en) * | 1988-11-30 | 1993-11-02 | Novapharme | 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions |
| US5464860A (en) * | 1988-11-30 | 1995-11-07 | Novapharme | N(pyrazol-3-yl) benzamides and pharmaceutical compositions |
| US5201932A (en) * | 1989-09-22 | 1993-04-13 | Basf Aktiengesellschaft | Carboxamides |
| DE4209849A1 (de) * | 1992-03-26 | 1993-09-30 | Basf Ag | Herstellung von Isoxazol-3-carbonsäureamid-4-carbonsäureestern durch selektive Amidierung |
| DE4214010A1 (de) * | 1992-04-29 | 1993-11-04 | Basf Ag | Isoxazolcarbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung |
| GB9209330D0 (en) * | 1992-04-30 | 1992-06-17 | Roussel Lab Ltd | Chemical compounds |
| TW314467B (fi) * | 1993-03-31 | 1997-09-01 | Hoechst Ag | |
| WO1994024095A1 (en) * | 1993-04-16 | 1994-10-27 | Abbott Laboratories | Immunosuppressive agents |
| CA2117413C (en) * | 1993-07-30 | 2006-11-21 | Neil Geach | Herbicidal isoxazole-4-yl-methanone derivatives |
| US5430536A (en) * | 1993-10-12 | 1995-07-04 | Xerox Corporation | Automatic duplex and simplex document handler for electronic input |
| EP0787491B1 (en) * | 1994-10-17 | 2000-07-26 | Aventis Pharma Ltd. | Preventive and remedy for type i allergic diseases |
| JPH10158192A (ja) | 1996-10-03 | 1998-06-16 | Eisai Co Ltd | 移植片対宿主疾患（ｇｖｈｄ）の治療および臓器移植時の移植片拒絶反応抑制のための医薬組成物 |
| US6206913B1 (en) * | 1998-08-12 | 2001-03-27 | Vascular Innovations, Inc. | Method and system for attaching a graft to a blood vessel |
| MXPA04000224A (es) * | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
| DE10162684A1 (de) * | 2001-12-19 | 2003-07-10 | Bayer Ag | Verfahren zur Herstellung von Aminen |
| US7365094B2 (en) | 2002-12-23 | 2008-04-29 | 4Sc Ag | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| EP1581478A1 (en) * | 2002-12-23 | 2005-10-05 | 4Sc Ag | Dhodh-inhibitors and method for their identification |
| US7247736B2 (en) | 2002-12-23 | 2007-07-24 | 4Sc Ag | Method of identifying inhibitors of DHODH |
| EP1541198A1 (en) * | 2003-12-05 | 2005-06-15 | 4Sc Ag | Cycloalkyl compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| WO2004056746A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
| EP1715334A1 (fr) | 2005-04-22 | 2006-10-25 | Adamant Technologies SA | Procédé utilisant un capteur électrochimique et électrodes formant ce capteur |
| US8952176B2 (en) * | 2005-06-07 | 2015-02-10 | Shionogi & Co., Ltd. | Heterocyclic compound having type I 11 β hydroxysteroid dehydrogenase inhibitory activity |
| EP2006286A4 (en) * | 2006-03-30 | 2010-04-07 | Shionogi & Co | ISOXAZOLE DERIVATIVE AND ISOTHIAZONE DERIVATIVITY WITH ANTICIPATING EFFECT ON 11 TYPE I BETA HYDROXYSTEROIDDEHYDROGENASE |
| CN104350051B (zh) * | 2011-11-23 | 2017-03-08 | 德克萨斯大学系统董事会 | 用于糖尿病的异噁唑治疗剂 |
| CN105622537A (zh) * | 2016-03-01 | 2016-06-01 | 青岛大学 | 一种3,4,5-三取代异恶唑类化合物的合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1019563A (en) * | 1961-08-18 | 1966-02-09 | Pfizer & Co C | Octahydroanthracenes and preparation thereof |
| NL178596C (nl) * | 1975-06-05 | 1986-04-16 | Hoechst Ag | Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden. |
| DE2655009A1 (de) * | 1976-12-04 | 1978-06-15 | Hoechst Ag | Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel |
| DE2854439A1 (de) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
| US4284785A (en) * | 1979-12-19 | 1981-08-18 | American Cyanamid Company | Substituted phenyl esters of isoxazolecarboxylic acids |
| DE3247454A1 (de) * | 1982-12-22 | 1984-06-28 | Laboratorios Bago S.A., Buenos Aires | Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
| GB8619433D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
| GB8619432D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
| US4935434A (en) * | 1988-01-26 | 1990-06-19 | Bristol-Myers Company | Antiarthritic isoxazole-4-carboxamides |
-
1990
- 1990-02-02 US US07/474,430 patent/US5001124A/en not_active Expired - Fee Related
-
1991
- 1991-01-25 IL IL97050A patent/IL97050A0/xx unknown
- 1991-02-01 KR KR1019910001783A patent/KR910021388A/ko not_active Application Discontinuation
- 1991-02-01 ZA ZA91782A patent/ZA91782B/xx unknown
- 1991-02-01 PH PH41927A patent/PH27573A/en unknown
- 1991-02-01 NO NO91910395A patent/NO910395L/no unknown
- 1991-02-01 AU AU70165/91A patent/AU643494B2/en not_active Ceased
- 1991-02-01 JP JP3216687A patent/JPH06340641A/ja active Pending
- 1991-02-01 IE IE034891A patent/IE910348A1/en unknown
- 1991-02-01 CA CA002035544A patent/CA2035544A1/en not_active Abandoned
- 1991-02-01 HU HU91354A patent/HUT60479A/hu unknown
- 1991-02-01 EP EP91300837A patent/EP0440503A1/en not_active Ceased
- 1991-02-01 FI FI910503A patent/FI910503A/fi not_active Application Discontinuation
- 1991-02-01 PT PT96633A patent/PT96633A/pt unknown
- 1991-02-01 TW TW080100816A patent/TW207534B/zh active
- 1991-02-01 NZ NZ236985A patent/NZ236985A/xx unknown
-
1992
- 1992-01-08 US US07/818,185 patent/US5328907A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PH27573A (en) | 1993-08-18 |
| ZA91782B (en) | 1992-10-28 |
| FI910503A (fi) | 1991-08-03 |
| US5328907A (en) | 1994-07-12 |
| PT96633A (pt) | 1991-10-31 |
| KR910021388A (ko) | 1991-12-20 |
| US5001124A (en) | 1991-03-19 |
| NO910395D0 (no) | 1991-02-01 |
| CA2035544A1 (en) | 1991-08-03 |
| JPH06340641A (ja) | 1994-12-13 |
| FI910503A0 (fi) | 1991-02-01 |
| HU910354D0 (en) | 1991-08-28 |
| AU7016591A (en) | 1991-08-08 |
| IL97050A0 (en) | 1992-03-29 |
| TW207534B (fi) | 1993-06-11 |
| NZ236985A (en) | 1993-04-28 |
| AU643494B2 (en) | 1993-11-18 |
| IE910348A1 (en) | 1991-08-14 |
| EP0440503A1 (en) | 1991-08-07 |
| HUT60479A (en) | 1992-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO910395L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater. | |
| NO913234D0 (no) | Fremgangsmaate for fremstilling av pyrazolderivater. | |
| NO914667L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater | |
| NO904694D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO901684D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO914825D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme alfa-oxoacetamider | |
| NO912051D0 (no) | Fremgangsmaate for fremstilling av azolderivater. | |
| NO902411D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. | |
| NO912411D0 (no) | Fremgangsmaate for fremstilling av bicykliske heterocykliske forbindelser. | |
| NO912346L (no) | Fremgangsmaate for fremstilling av aminobenzodiazepiner. | |
| NO912797D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater. | |
| NO911065D0 (no) | Fremgangsmaate for fremstilling av lipopeptidderivater. | |
| NO914053L (no) | Fremgangsmaate for fremstilling av 8-klorokinolonderivater | |
| NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
| NO913692D0 (no) | Fremgangsmaate for fremstilling av karbapenemforbindelser. | |
| NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
| NO913187L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater. | |
| NO912979D0 (no) | Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenederivater. | |
| NO914985D0 (no) | Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater | |
| NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO903397L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd. | |
| NO911672L (no) | Fremgangsmaate for fremstilling av alkansulfonanilid-derivater. | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO914452L (no) | Fremgangsmaate for fremstilling av isokinolinderivater | |
| NO913429D0 (no) | Fremgangsmaate for fremstilling av 5-benzyl-substituerte benzimidazolin-2-tion-derivater. |